For U.S. Healthcare Professionals

Visit Janssen CarePath

Once a decision has been made to prescribe OPSUMIT®

J&J withMe is a Suite of Access, Affordability, and Treatment Support Resources for Your Patients

At Johnson & Johnson, we are committed to helping people live fuller lives. Our J&J withMe program is here at every step to provide personalized support to help your patient start and stay on a prescribed J&J medicine.

The patient support and resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan from the patients doctor or nurse, provide case management services, or serve as a reason to prescribe.

Download the Enrollment and Prescription Form

Support for patients using commercial or private insurance to pay for medicine

J&J withMe Oral PAH Savings Program can help eligible patients save on their out-of pocket medicine costs for OPSUMIT®. Depending on the patient's health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Your eligible patients will pay $5 per prescription fill. Maximum program benefit per calendar year shall apply across all oral PAH therapies in the program. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medicines. Terms expire at the end of each calendar year. Offer subject to change or end without notice. Restrictions, including monthly maximums, may apply. Patients may participate without sharing their income information. See program requirements at OPSUMIT.JNJwithMeSavings.com

opsynvi card visuals

Johnson & Johnson Patient Assistance Program

Additional Affordability Support

Patient assistance from Johnson & Johnson is available if your patient is uninsured or has commercial, employer-sponsored, or government coverage that does not fully meet their needs. Your Patient may be eligible to receive their medicine from J&J at no cost for up to one year if they meet the eligibility and income requirements for Johnson & Johnson Patient Assistance Program. See terms and conditions at PatientAssistanceInfoPH.com or call 866-228-3546.

Downloadable Resources

BACK TO TOP

*Based on the proportion of patients who engaged in the program versus those who did not engage in the program and were still on therapy 120 days after treatment initiation. Analysis of J&J HUB data derived from specialty pharmacy transactions from 4/1/23 – 3/31/24.
PAH=pulmonary arterial hypertension.
References: 1. Johnson & Johnson and its affiliates. Data on file. J&J HUB and specialty pharmacy transaction data. 4/1/23 –3/31/24. 2. Data on file. Ashfield Post Engagement Survey (IVR and email), 2022. 3. Data on file. J&J Strategic Insights and Analytics Team Dashboard/Data Feed from Ashfield (Companion Vendor).

EXPAND +

+ +